Form 8-K
Material Company Update
2026-04-17
ABT filed 8-K — material company event
ABBOTT LABORATORIES filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Latest SEC filings for Abbott Laboratories (ABT) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
ABBOTT LABORATORIES filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
ABBOTT LABORATORIES filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Stratton John G (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Roman Michael F (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Gonzalez Patricia Paola (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Alpern Robert J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Ahuja Nita (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
ORVILLE JACOB A (Senior Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
ABBOTT LABORATORIES filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
ABBOTT LABORATORIES filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Shroff Eric, listed as Senior Vice President at ABBOTT LABORATORIES, reported an open-market sale of 709 ABT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Scoggins Christopher J (EXECUTIVE VICE PRESIDENT) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Salvadori Daniel Gesua Sive, listed as EVP AND GROUP PRESIDENT at ABBOTT LABORATORIES, reported an open-market sale of 885 ABT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Morrone Louis H., listed as EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES, reported an open-market sale of 1,144 ABT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Moreland Mary K, listed as EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES, reported an open-market sale of 613 ABT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.